Phase II trial with Brequinar (DUP-785, NSC 368390) in patients with metastatic colorectal cancer: a study of the Early Clinical Trials Group of the EORTC

Ann Oncol. 1990;1(1):79-80. doi: 10.1093/oxfordjournals.annonc.a057680.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / secondary*
  • Adult
  • Animals
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Biphenyl Compounds / adverse effects
  • Biphenyl Compounds / therapeutic use*
  • Colorectal Neoplasms / pathology*
  • Drug Evaluation
  • Female
  • Humans
  • Male
  • Middle Aged

Substances

  • Antineoplastic Agents
  • Biphenyl Compounds
  • brequinar